University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 1 of 21
My Path to Quit Tobacco
NCT07419425
Speech Production Enhancement Using Augmentative Communication for Kids
NCT07173049
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
NCT05521698
Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During Sleep
NCT07498270
Improving Preterm Kidney Outcomes With Caffeine
NCT07262060
Defy The Odds: Exercise Forecasting and Motivation Strategies for Prolonged-Sitting Jobs
NCT07475130
Ambient AI for Reducing Nursing Staff Documentation Time
NCT07456241
Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts
NCT07440004
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
NCT07197671
Validation of Presence-IP1.0 for Detection of Consciousness Using Reduced-Montage TMS-EEG
NCT07523191
The COMParing App Support Strategies Study
NCT07278466
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
NCT07090148
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
NCT07125209
Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
NCT07343596
Music Interventions During Wide-Awake Hand Surgery
NCT05472909
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
NCT07281924
Evaluating the Communication Between Patients and Providers in Cancer Clinics
NCT06985953
Using FAPI PET/MRI to Evaluate Prostate Cancer
NCT06675357
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
NCT07285668
Brain Blood Vessel Responses to Changes in Blood Flow
NCT06629077
Hearing Aid Benefit in Real-World Noisy Environments
NCT07226167
The ORIGIN-FH Study
NCT07470723
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
NCT06840899
Comparing Outcomes and Complications Following Mastisol Application for Clubfoot Casting
NCT07154550
Testing MOUD Scale-Up
NCT07224516
Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
NCT07532083
Implementation Pilot of Preoperative CGA Before Major Surgery
NCT06184724
Evaluation of CT-XPI
NCT07192133
Painful Post-Operative Hip Study
NCT07066709
Well-being Skills for Reentry
NCT06975657
Full Plate Living Nutrition Education Program
NCT07271940
ORCHARDS-AIR Study
NCT07298967
Exercise-priming of CBT for Depression: the CBT+ Trial
NCT07221929
Aerodynamic Measurements in the Pediatric Population
NCT06975046
PTSD Treatment for Incarcerated Men and Women: AV
NCT07283757
Power Nap With TES-TI
NCT07090135
Brain Blood Vessel Responses to Changes in Blood Flow: Younger Cohort
NCT06629090
Effect of TXA on Reducing Bruising After Filler Injection
NCT06665594
Temporal Interference for Thalamocortical Activity and Network Modulation
NCT07219719
Exercise and Carotid Artery Function in Metabolic Syndrome
NCT07430839
Evaluation of Pediatric eCART Implementation
NCT06771830
Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework
NCT07559253
Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
NCT06940427
Developing Remote Human Milk Collection as a Novel Technique for Transcriptome Sequencing
NCT07118852
Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline
NCT07044596
Dermabrasion in Mohs: Split-Scar Trial
NCT07213921
Brain Health in Transgender Adults
NCT07624747
HEARTS Trial for Thoracic Cancers
NCT07132918
Optimizing Smart Technology for Addiction Recovery
NCT07573540
Calls and Coordination for Transitions of Care at Re-entry
NCT06794983
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets.Report a data error.